Diabetes, a chronic disease burdening over 550 million individuals worldwide, has long been regarded as a lifelong affliction. However, emerging research tantalizingly suggests that remission, albeit rare, may be within reach. In this article, we delve deep into the findings of two groundbreaking studies exploring the incidence and predictors of remission and relapse in individuals with type 2 diabetes.
Diabetes Testing
A Glimmer of Hope
A team of dedicated researchers and clinicians from the University of Niigata in Japan embarked on a comprehensive study, which culminated in the discovery of a modest diabetes remission rate. Their research, meticulously documented in the renowned journal Diabetes Obesity and Metabolism, revealed that in real-world settings, approximately 1 in 100 individuals diagnosed with type 2 diabetes achieved remission.
Read Also: Intermittent Fasting Can Help Patients with Diabetes Beat Their Condition Study Shows
Remission, a state characterized by the return to normal blood sugar levels and the cessation of medication reliance, can manifest in a select few type 2 diabetes patients. This transformative phenomenon is contingent upon several factors: the adoption of a healthy lifestyle, temporary pharmacological treatment adherence, bariatric or weight loss surgery, or a skillful fusion of these variables.
However, the research team cautions that the intricacies of this remission phenomenon remain enigmatic, particularly within routine care contexts. A myriad of factors remains to be illuminated, including the influence of ethnic origins on these remission “opportunities.”
The Interplay of Remission and Relapse
The study sought to meticulously assess the probability of remission and the incidence of relapses within the year following the remission state, while scrutinizing the associated factors influencing individuals with type 2 diabetes. To achieve this, the researchers meticulously examined data obtained from the Japan Diabetes Clinical Data Management Study Group (JDDM), an expansive cohort consisting of 48,320 Japanese participants with type 2 diabetes, collectively followed for an average of 5 years.
The study yielded remarkable insights. The overall incidence of remission per 1000 person-years was found to be 10.5. Notably, for individuals with HbA1c levels ranging from 48 to 53 mmol/mol (6.5% to 6.9%), those not consuming glucose-lowering drugs at baseline, and those achieving a remarkable ≥10% reduction in body mass index (BMI) within 1 year, the remission rates reached 27.8, 21.7, and 48.2, respectively.
Read Also: Diabetes Treatment: New Cryopreservation Protocol Increases the Supply of Pancreatic Islets
Factors favoring remission included male gender, shorter diabetes duration, lower initial HbA1c levels, higher initial BMI, substantial BMI reduction within 1 year, and a lack of glucose-lowering medications at the study’s inception. Remarkably, similar factors favored the maintenance of remission over the span of 1 year.
However, amidst the 3677 individuals who successfully attained remission, approximately two-thirds (2490) experienced relapse within the first year. Factors significantly associated with relapse included prolonged diabetes duration, lower initial BMI, and a less substantial BMI reduction within 1 year.
Ethnic Nuances
The study sheds light on noteworthy variations in insulin secretion and resistance across diverse ethnic groups, most notably between East Asian and Western populations. Asians, who exhibit considerably lower obesity rates than their Western counterparts, showcased distinctive relationships between baseline BMI and the propensity for remission and relapse, thus underscoring the potentially amplified influence of baseline BMI in East Asian populations.
Read Also: Type 1 Diabetes: Stem Cell Treatment Successfully Treats a 64-Year-Old Man
While these findings are undeniably impressive, cautious interpretation is crucial. The study, albeit groundbreaking, reveals associations rather than cause-and-effect relationships. Nonetheless, it injects a renewed sense of hope and invites fresh perspectives on the prospect of diabetes remission, thereby stimulating further research and understanding in this important field.
Final thoughts
The path towards diabetes remission proves intricate and multifaceted, influenced by a diverse array of factors spanning lifestyle alterations to ethnic origins. While the incidence of remission may be modest, these revelatory studies provide invaluable insights into the potential for remission and the multifarious factors that shape its occurrence. They resolutely underscore the paramount significance of personalized treatment plans that conscientiously consider individual patient characteristics and circumstances. As the relentless pursuit of knowledge continues, we hold steadfast hope for the development of more effective strategies to manage diabetes and heighten the prospects of remission.
Read Also: Scientists Improve Efficiency of Stem Cell Transplants in Diabetes Management
References
Fujihara, K., Khin, L., Murai, K., Yamazaki, Y., Tsuruoka, K., Yagyuda, N., Yamazaki, K., Maegawa, H., Tanaka, S., Kodama, S., Sone, H., & JDDM Study Group. (2023). Incidence and predictors of remission and relapse of type 2 diabetes mellitus in Japan: Analysis of a nationwide patient registry (JDDM73). Diabetes, Obesity and Metabolism, 25(8). https://doi.org/10.1111/dom.15100
FEEDBACK:
